Omeros Corporation
OMER
$3.15
Share price
2.94%
Change (1 day)
-45.69%
Change (1 year)
Categories
Revenue for Omeros Corporation (OMER)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of N/A an increase over the years 2021 revenue that were of -$79.89 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Omeros Corporation from 2009 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | N/A | |
| 2022 | N/A | -100% |
| 2021 | -$79.89 M | -208.23% |
| 2020 | $73.81 M | -33.98% |
| 2019 | $0.11 B | 274.34% |
| 2018 | $29.86 M | -53.93% |
| 2017 | $64.82 M | 55.77% |
| 2016 | $41.61 M | 208.07% |
| 2015 | $13.5 M | 2406.31% |
| 2014 | $0.53 M | -66.31% |
| 2013 | $1.6 M | -73.43% |
| 2012 | $6.02 M | 33.11% |
| 2011 | $4.52 M | 114.92% |
| 2010 | $2.1 M | 45.78% |
| 2009 | $1.44 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $93.02 B | N/A | 🇺🇸 USA |
 Pfizer PFE | $58.49 B | N/A | 🇺🇸 USA |
 Genetic Technologies GENE | $17.17 M | N/A | 🇦🇺 Australia |
 Eterna Therapeutics ERNA | $0.06 M | N/A | 🇺🇸 USA |